| Expression pattern: |
UP |
| Associated gene: |
E2F1, TFCP2, RBM41 |
| Associated microRNA: |
hsa-miR-136, hsa-miR-1229, hsa-miR-1273, hsa-miR-618 |
| Biological function: |
promotes CSCC cell differentiation, proliferation, and metastasis |
| Molecular mechanism: |
Predicted ceRNA mechanism (miRNA sponge) involving hsa-miR-136 (and other miRNAs) and downstream target genes identified by Oncomine analysis |
| Biological pathway or process: |
ceRNA regulation (promotes); proliferation (promotes); metastasis (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; Bioinformatics Analysis; Clinical Sample Validation |
| Clinical significance: |
potential diagnostic and therapeutic biomarkers |
| Description: |
hsa_circ_0000745 is up-regulated in CSCC tissues and is proposed to act through a ceRNA network by targeting miRNAs (e.g., hsa-miR-136) and affecting downstream genes such as E2F1/TFCP2/RBM41. Its overexpression is associated with promoting CSCC cell differentiation, proliferation, and metastasis. |
| Confidence score: |
0.4032 |